Limbic, a leading clinical mental health AI technology company with offices in New York City and London, has successfully raised $14 million in funding. The investment round was led by Khosla Ventures, a prominent venture capital firm based in the United States, with participation from Gaingels, an LGBTQIA+ investment syndicate, and Illusian, the family office of Ilkka Paananen, co-founder of Supercell.

This recent influx of capital marks a significant milestone for Limbic as it aims to broaden the availability of its clinical mental health AI services to healthcare providers across the United States. Under the leadership of CEO Dr. Ross Harper, Limbic has developed innovative AI technology designed to augment the capabilities of human clinicians and extend high-quality mental health care to individuals in need.

The core offering from Limbic is a care companion powered by AI, which serves as a support tool for users between therapy sessions. Through a chatbot interface driven by sophisticated clinical AI algorithms, patients can access a curated selection of 100 themed activities and educational materials tailored to their mental health needs. This on-demand support system has already proven its effectiveness, having assisted over 260,000 patients within the UK’s National Health Service (NHS) Talking Therapies program.

One of the key advantages of Limbic’s AI solution is its ability to increase access to mental health services, particularly among minority communities. Recent studies have shown a significant uptick in mental health referrals among ethnic and sexual minority groups utilizing Limbic’s technology, including a 179% increase among non-binary individuals and substantial rises among Asian and Black mental health patients.

Moreover, Limbic’s AI chatbot has been instrumental in streamlining the diagnostic process for clinicians, saving an estimated 50,000 hours of work by automating patient assessment and referral tasks. Despite concerns about data privacy and the use of AI in mental health support, Limbic has implemented robust safeguards, including real-time alerts to healthcare providers in cases where a patient may require urgent attention.

With the additional funding secured, Limbic is poised to make further inroads into the U.S. healthcare market, where the demand for innovative mental health solutions is particularly acute. By leveraging its proven track record of success and commitment to advancing equitable access to care, Limbic aims to revolutionize the delivery of mental health services on a global scale.

For more such insightful news & updates around AI or Automation, explore other articles here. You can also follow us on Twitter.